This report aims to provide a comprehensive presentation of the global market for Haemato Oncology Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemato Oncology Testing. This report contains market size and forecasts of Haemato Oncology Testing in global, including the following market information:
Global Haemato Oncology Testing Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Haemato Oncology Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Leukaemia Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Haemato Oncology Testing include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, Haplox, Amoy Dx, Genosaber and YZY Biopharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Haemato Oncology Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Haemato Oncology Testing Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Haemato Oncology Testing Market Segment Percentages, by Type, 2022 (%)
Leukaemia
Lymphoma
Hodgkin Lymphoma
Others
Global Haemato Oncology Testing Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Haemato Oncology Testing Market Segment Percentages, by Application, 2022 (%)
Clinical Laboratories
Hospitals
Academic and Research Institutes
Others
Global Haemato Oncology Testing Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Haemato Oncology Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Haemato Oncology Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Haemato Oncology Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Berry Genomics
Burning Rock Dx
BGI
Genetron
Haplox
Amoy Dx
Genosaber
YZY Biopharma
Wondfo
Outline of Major Chapters:
Chapter 1: Introduces the definition of Haemato Oncology Testing, market overview.
Chapter 2: Global Haemato Oncology Testing market size in revenue.
Chapter 3: Detailed analysis of Haemato Oncology Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Haemato Oncology Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Haemato Oncology Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Haemato Oncology Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Haemato Oncology Testing Overall Market Size
2.1 Global Haemato Oncology Testing Market Size: 2022 VS 2030
2.2 Global Haemato Oncology Testing Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Haemato Oncology Testing Players in Global Market
3.2 Top Global Haemato Oncology Testing Companies Ranked by Revenue
3.3 Global Haemato Oncology Testing Revenue by Companies
3.4 Top 3 and Top 5 Haemato Oncology Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Haemato Oncology Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Haemato Oncology Testing Players in Global Market
3.6.1 List of Global Tier 1 Haemato Oncology Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Haemato Oncology Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Haemato Oncology Testing Market Size Markets, 2022 & 2030
4.1.2 Leukaemia
4.1.3 Lymphoma
4.1.4 Hodgkin Lymphoma
4.1.5 Others
4.2 By Type - Global Haemato Oncology Testing Revenue & Forecasts
4.2.1 By Type - Global Haemato Oncology Testing Revenue, 2018-2023
4.2.2 By Type - Global Haemato Oncology Testing Revenue, 2024-2030
4.2.3 By Type - Global Haemato Oncology Testing Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Haemato Oncology Testing Market Size, 2022 & 2030
5.1.2 Clinical Laboratories
5.1.3 Hospitals
5.1.4 Academic and Research Institutes
5.1.5 Others
5.2 By Application - Global Haemato Oncology Testing Revenue & Forecasts
5.2.1 By Application - Global Haemato Oncology Testing Revenue, 2018-2023
5.2.2 By Application - Global Haemato Oncology Testing Revenue, 2024-2030
5.2.3 By Application - Global Haemato Oncology Testing Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Haemato Oncology Testing Market Size, 2022 & 2030
6.2 By Region - Global Haemato Oncology Testing Revenue & Forecasts
6.2.1 By Region - Global Haemato Oncology Testing Revenue, 2018-2023
6.2.2 By Region - Global Haemato Oncology Testing Revenue, 2024-2030
6.2.3 By Region - Global Haemato Oncology Testing Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Haemato Oncology Testing Revenue, 2018-2030
6.3.2 US Haemato Oncology Testing Market Size, 2018-2030
6.3.3 Canada Haemato Oncology Testing Market Size, 2018-2030
6.3.4 Mexico Haemato Oncology Testing Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Haemato Oncology Testing Revenue, 2018-2030
6.4.2 Germany Haemato Oncology Testing Market Size, 2018-2030
6.4.3 France Haemato Oncology Testing Market Size, 2018-2030
6.4.4 U.K. Haemato Oncology Testing Market Size, 2018-2030
6.4.5 Italy Haemato Oncology Testing Market Size, 2018-2030
6.4.6 Russia Haemato Oncology Testing Market Size, 2018-2030
6.4.7 Nordic Countries Haemato Oncology Testing Market Size, 2018-2030
6.4.8 Benelux Haemato Oncology Testing Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Haemato Oncology Testing Revenue, 2018-2030
6.5.2 China Haemato Oncology Testing Market Size, 2018-2030
6.5.3 Japan Haemato Oncology Testing Market Size, 2018-2030
6.5.4 South Korea Haemato Oncology Testing Market Size, 2018-2030
6.5.5 Southeast Asia Haemato Oncology Testing Market Size, 2018-2030
6.5.6 India Haemato Oncology Testing Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Haemato Oncology Testing Revenue, 2018-2030
6.6.2 Brazil Haemato Oncology Testing Market Size, 2018-2030
6.6.3 Argentina Haemato Oncology Testing Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Haemato Oncology Testing Revenue, 2018-2030
6.7.2 Turkey Haemato Oncology Testing Market Size, 2018-2030
6.7.3 Israel Haemato Oncology Testing Market Size, 2018-2030
6.7.4 Saudi Arabia Haemato Oncology Testing Market Size, 2018-2030
6.7.5 UAE Haemato Oncology Testing Market Size, 2018-2030
7 Haemato Oncology Testing Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Haemato Oncology Testing Major Product Offerings
7.1.4 Roche Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Berry Genomics
7.2.1 Berry Genomics Company Summary
7.2.2 Berry Genomics Business Overview
7.2.3 Berry Genomics Haemato Oncology Testing Major Product Offerings
7.2.4 Berry Genomics Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.2.5 Berry Genomics Key News & Latest Developments
7.3 Burning Rock Dx
7.3.1 Burning Rock Dx Company Summary
7.3.2 Burning Rock Dx Business Overview
7.3.3 Burning Rock Dx Haemato Oncology Testing Major Product Offerings
7.3.4 Burning Rock Dx Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.3.5 Burning Rock Dx Key News & Latest Developments
7.4 BGI
7.4.1 BGI Company Summary
7.4.2 BGI Business Overview
7.4.3 BGI Haemato Oncology Testing Major Product Offerings
7.4.4 BGI Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.4.5 BGI Key News & Latest Developments
7.5 Genetron
7.5.1 Genetron Company Summary
7.5.2 Genetron Business Overview
7.5.3 Genetron Haemato Oncology Testing Major Product Offerings
7.5.4 Genetron Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.5.5 Genetron Key News & Latest Developments
7.6 Haplox
7.6.1 Haplox Company Summary
7.6.2 Haplox Business Overview
7.6.3 Haplox Haemato Oncology Testing Major Product Offerings
7.6.4 Haplox Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.6.5 Haplox Key News & Latest Developments
7.7 Amoy Dx
7.7.1 Amoy Dx Company Summary
7.7.2 Amoy Dx Business Overview
7.7.3 Amoy Dx Haemato Oncology Testing Major Product Offerings
7.7.4 Amoy Dx Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.7.5 Amoy Dx Key News & Latest Developments
7.8 Genosaber
7.8.1 Genosaber Company Summary
7.8.2 Genosaber Business Overview
7.8.3 Genosaber Haemato Oncology Testing Major Product Offerings
7.8.4 Genosaber Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.8.5 Genosaber Key News & Latest Developments
7.9 YZY Biopharma
7.9.1 YZY Biopharma Company Summary
7.9.2 YZY Biopharma Business Overview
7.9.3 YZY Biopharma Haemato Oncology Testing Major Product Offerings
7.9.4 YZY Biopharma Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.9.5 YZY Biopharma Key News & Latest Developments
7.10 Wondfo
7.10.1 Wondfo Company Summary
7.10.2 Wondfo Business Overview
7.10.3 Wondfo Haemato Oncology Testing Major Product Offerings
7.10.4 Wondfo Haemato Oncology Testing Revenue in Global Market (2018-2023)
7.10.5 Wondfo Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Haemato Oncology Testing Market Opportunities & Trends in Global Market
Table 2. Haemato Oncology Testing Market Drivers in Global Market
Table 3. Haemato Oncology Testing Market Restraints in Global Market
Table 4. Key Players of Haemato Oncology Testing in Global Market
Table 5. Top Haemato Oncology Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Haemato Oncology Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Haemato Oncology Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Haemato Oncology Testing Product Type
Table 9. List of Global Tier 1 Haemato Oncology Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Haemato Oncology Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Haemato Oncology Testing Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Haemato Oncology Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Haemato Oncology Testing Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Haemato Oncology Testing Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Haemato Oncology Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Haemato Oncology Testing Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Haemato Oncology Testing Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Haemato Oncology Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Haemato Oncology Testing Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Haemato Oncology Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Haemato Oncology Testing Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Haemato Oncology Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Haemato Oncology Testing Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Haemato Oncology Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Haemato Oncology Testing Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Haemato Oncology Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Haemato Oncology Testing Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Haemato Oncology Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Haemato Oncology Testing Revenue, (US$, Mn), 2024-2030
Table 30. Roche Company Summary
Table 31. Roche Haemato Oncology Testing Product Offerings
Table 32. Roche Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Berry Genomics Company Summary
Table 35. Berry Genomics Haemato Oncology Testing Product Offerings
Table 36. Berry Genomics Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Berry Genomics Key News & Latest Developments
Table 38. Burning Rock Dx Company Summary
Table 39. Burning Rock Dx Haemato Oncology Testing Product Offerings
Table 40. Burning Rock Dx Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Burning Rock Dx Key News & Latest Developments
Table 42. BGI Company Summary
Table 43. BGI Haemato Oncology Testing Product Offerings
Table 44. BGI Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 45. BGI Key News & Latest Developments
Table 46. Genetron Company Summary
Table 47. Genetron Haemato Oncology Testing Product Offerings
Table 48. Genetron Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Genetron Key News & Latest Developments
Table 50. Haplox Company Summary
Table 51. Haplox Haemato Oncology Testing Product Offerings
Table 52. Haplox Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Haplox Key News & Latest Developments
Table 54. Amoy Dx Company Summary
Table 55. Amoy Dx Haemato Oncology Testing Product Offerings
Table 56. Amoy Dx Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Amoy Dx Key News & Latest Developments
Table 58. Genosaber Company Summary
Table 59. Genosaber Haemato Oncology Testing Product Offerings
Table 60. Genosaber Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Genosaber Key News & Latest Developments
Table 62. YZY Biopharma Company Summary
Table 63. YZY Biopharma Haemato Oncology Testing Product Offerings
Table 64. YZY Biopharma Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 65. YZY Biopharma Key News & Latest Developments
Table 66. Wondfo Company Summary
Table 67. Wondfo Haemato Oncology Testing Product Offerings
Table 68. Wondfo Haemato Oncology Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Wondfo Key News & Latest Developments
List of Figures
Figure 1. Haemato Oncology Testing Segment by Type in 2022
Figure 2. Haemato Oncology Testing Segment by Application in 2022
Figure 3. Global Haemato Oncology Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Haemato Oncology Testing Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Haemato Oncology Testing Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Haemato Oncology Testing Revenue in 2022
Figure 8. By Type - Global Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 9. By Application - Global Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 10. By Type - Global Haemato Oncology Testing Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 12. By Application - Global Haemato Oncology Testing Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 14. By Region - Global Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 15. By Country - North America Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 16. US Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 20. Germany Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 21. France Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 28. China Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 32. India Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 34. Brazil Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Haemato Oncology Testing Revenue Market Share, 2018-2030
Figure 37. Turkey Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Haemato Oncology Testing Revenue, (US$, Mn), 2018-2030
Figure 41. Roche Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Berry Genomics Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Burning Rock Dx Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BGI Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Genetron Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Haplox Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Amoy Dx Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Genosaber Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. YZY Biopharma Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Wondfo Haemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
